Whitehawk Therapeutics (WHWK) Other Gross PP&E Adjustments (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Other Gross PP&E Adjustments of -$1.3 million for Q1 2026, down 449.34% year-over-year from $377000.0 in Q1 2025, and down 122.84% quarter-over-quarter from -$591000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Other Gross PP&E Adjustments (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 11 years of Other Gross PP&E Adjustments data on file, last reported at -$1.3 million in Q1 2026.
- Other Gross PP&E Adjustments for Q1 2026 came in at -$1.3 million, down 449.34% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 449.34% YoY), and the FY2025 annual result was -$591000.0, down 143.3% from the prior year.
- Other Gross PP&E Adjustments retreated to -$1.3 million in Q1 2026 per WHWK's latest filing, from -$591000.0 in the prior quarter.
- Over five years, Other Gross PP&E Adjustments peaked at $5.5 million in Q3 2024 and troughed at -$1.7 million in Q2 2022.
- A 5-year average of $1.2 million and a median of $377000.0 in 2025 frame the typical range for Other Gross PP&E Adjustments.
- The sharpest annual moves came in 2023 and 2026: Other Gross PP&E Adjustments jumped 527.49% in 2023, then slumped 449.34% in 2026.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$913000.0 in 2022, then jumped by 527.49% to $3.9 million in 2023, then sank by 65.03% to $1.4 million in 2024, then plunged by 143.3% to -$591000.0 in 2025, then tumbled by 122.84% to -$1.3 million in 2026.
- Business Quant data shows WHWK's Other Gross PP&E Adjustments at -$1.3 million in Q1 2026, -$591000.0 in Q4 2025, and -$459000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -60,691.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -83,048.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -285.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -892,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -1.69 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Whitehawk Therapeutics | 288.03 Mn | 164.98 Mn | - | -1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.32 Mn |
| Mar 31, 2026 | -1.32 Mn |
| Dec 31, 2025 | -591,000.00 |
| Dec 31, 2025 | -591,000.00 |
| Sep 30, 2025 | -459,000.00 |
| Sep 30, 2025 | -459,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Dec 31, 2024 | 1.37 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 5.51 Mn |
| Sep 30, 2024 | 5.51 Mn |
| Jun 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 5.39 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Dec 31, 2023 | 3.90 Mn |